Comparative study of hydroethanolic extract of Terminalia mantaly on Staphylococcus aureus ATCC and Salmonella typhi

OUATTARA Sitapha 1, *, BAGRE Issa 1, KPOROU Kouassi Elisée 3, SORO Yédé Débora 1, KRA Adou Koffi Mathieu 1 and DJAMAN Allico Joseph 1, 2

1 Biology and Health Laboratory, Felix Houphouet-Boigny University, Cococdy, Abidjan, Ivory Coast, 22 BP 582 Abidjan  22.
2 Medical and fundamental Biochemistry, Pasteur Institute / Company, Cococdy, Abidjan, Ivory Coast, 01 BP 490 Abidjan 01.
3 Department of Biochemistry and Microbiology, Research Unit of Bioactive Natural Substances, Jean Lorougnon Guede University, Daloa, Ivory Coast, BP 150 Daloa .
 
Research Article
World Journal of Advanced Pharmaceutical and Life Sciences, 2022, 03(02), 011–015.
Article DOI: 10.53346/wjapls.2022.3.2.0039
Publication history: 
Received on 17 October 2022; revised on 03 December 2022; accepted on 06 December 2022
 
Abstract: 
In the present work, antibacterial activity of a hydroethanolic extract of Terminalia mantaly was verified on two bacteriam strains Staphylococcus aureus American Type Culture Collection (ATCC) and Salmonella typhi in petri dishes by comparing the diameters of the different inhibition zones. The hydroethanolic extract of Terminalia mantaly was prepared with a solvent containing 70% ethanol and 30% distilled water. The Mueller-Hinton medium was poured into petri dishes and then the bacterial strains (Staphylococcus aureus ATCC and Salmonella typhi) were separately plated. Using the wells, the extract was introduced to record the diameters of the inhibition zone in order to assess the antibacterial activity. Oxacillin was used as a standard antibacterial. The results showed that the antibacterial activity is pronounced on Staphylococcus aureus ATCC compared to Salmonella typhi. These tests support the use of Terminalia mantaly against various bacterial diseases.
 
Keywords: 
Terminalia mantaly; Staphylococcus aureus ATCC; Salmonella typhi; Oxacillin; Hydroethanolic extract.
 
Full text article in PDF: